MICROTIA
Clinical trials for MICROTIA explained in plain language.
Never miss a new study
Get alerted when new MICROTIA trials appear
Sign up with your email to follow new studies for MICROTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental ear implant trial halted after only 3 patients
Disease control TerminatedThis study tested an experimental ear implant (AUR-201) for people aged 8 to 29 with a condition called unilateral microtia, where one ear is small or missing. The implant was made from the patient's own ear cartilage and placed under the skin to create a new ear shape. The study…
Matched conditions: MICROTIA
Phase: PHASE1, PHASE2 • Sponsor: Auregen Biotherapeutics, SA • Aim: Disease control
Last updated May 26, 2026 12:10 UTC
-
Ear implant trial ends early after just 2 patients
Disease control TerminatedThis early-stage study tested a custom ear-shaped implant (AUR-201) for people aged 8 to 29 with a condition called microtia, where one outer ear is underdeveloped. The goal was to see if the implant was safe and improved appearance. Only 2 people enrolled before the study was st…
Matched conditions: MICROTIA
Phase: PHASE1 • Sponsor: Auregen Biotherapeutics, SA • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Ear implant study ends early after just one participant
Disease control TerminatedThis study followed one person with microtia (an underdeveloped ear) who had already received an AUR-201 implant in an earlier study. The goal was to see how well the implant kept its shape and how safe it was over 96 weeks. The study was terminated early, so results are very lim…
Matched conditions: MICROTIA
Phase: PHASE1, PHASE2 • Sponsor: Auregen Biotherapeutics, SA • Aim: Disease control
Last updated May 18, 2026 12:02 UTC